MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fphar.2026.1790042

Медицинская библиотека · Frontiers in pharmacology · 2026

Feasibility of vancomycin AUC24 monitoring using peak and trough concentrations in pediatric patients: a prospective multicenter study.

Nahari Majed H, Alsultan Abdullah, Alshuraim Renad A, Altuwayjiri Abdullah, Alotaibi Sultan, Aljeraisy Majed

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Vancomycin remains a key medication in treating infections in pediatric patients, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA). Conventional trough-based monitoring has shown limited accuracy in predicting therapeutic exposure and nephrotoxicity. Recent guidelines recommend area under the concentration-time curve (AUC)-based monitoring, but pediatric evidence remains scarce. Our objective is to assess the feasibility of vancomycin AUC24 monitoring using peak-trough concentrations in routine pediatric clinical practice and examine its correlation with the trough levels.

METHODS

We conducted a prospective, multicenter study in 70 pediatric inpatients receiving vancomycin at two tertiary hospitals in Riyadh, Saudi Arabia. Vancomycin AUC24 was calculated using first-order pharmacokinetics from peak and trough levels. AUC24 was compared with the trough concentrations and dosing regimens.

RESULTS

Implementation of AUC24-based monitoring was feasible in routine pediatric workflow. Pharmacists successfully calculated AUC24 using the Sanford Guide mobile app, with minimal training required for nurses on sampling. The correlation between the trough levels and AUC24 was strong (ρ = 0.789, p < 0.001), but the trough values did not consistently predict target attainment (AUC24 400 μg h/mL-600 μg h/mL). At trough concentrations of 10 μg/mL-15 μg/mL, only approximately half of the patients achieved the target AUC24 range (400 μg h/mL-600 μg h/mL), whereas at troughs of 15 μg/mL-20 μg/mL, nearly half of the patients exceeded the safe exposure thresholds, underscoring the limitations of trough-based monitoring.

CONCLUSION

AUC24 estimation from peak and trough samples was feasible in routine pediatric workflow, providing more accurate exposure assessment than trough-guided monitoring. Implementation may improve efficacy and minimize nephrotoxicity.

Для цитирования: Nahari Majed H, Alsultan Abdullah, Alshuraim Renad A, Altuwayjiri Abdullah, Alotaibi Sultan, Aljeraisy Majed. Feasibility of vancomycin AUC24 monitoring using peak and trough concentrations in pediatric patients: a prospective multicenter study.. Frontiers in pharmacology. 2026. DOI: 10.3389/fphar.2026.1790042.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.